Alzheimer’s Research Trust responds to Vitamin B3 research
The Alzheimer’s Research Trust, has reacted to the findings of a study into the effects of vitamin B3 in mice with Alzheimer’s disease.
Rebecca Wood, Chief Executive of the Alzheimer’s Research Trust, said:
“This research indicates that vitamin B3 could improve memory function in mice with Alzheimer’s. These are exciting findings, but until the results from the human clinical trial are announced, people should be wary about changing their diet or taking supplements. In high doses vitamin B3 can be toxic.
“The Alzheimer’s Research Trust is funding research into vitamins that could give a protective effect to try to identify ways of reducing people's risk of developing Alzheimer's. It can also help increase our understanding of the disease and ways to develop new treatments.
“We await the results of this exciting clinical trial.”
Similar entries
- Tests may predict driving safety in people with Alzheimer’s
- ‘Groundbreaking’ Alzheimer’s trial removes toxic brain plaques
- Funding boost for Alzheimer’s research in Cambridge
- UK pensioner income 'at 18-month low'
- UK pensioner income 'at 18-month low'
- 'Decent' state pension rise proposed: Press Association
- Call for abstracts: All-Ireland Social Medicine Meeting
- £30 million hope for dementia research
- Scientists closer to developing new dementia drugs
- Funding boost for Alzheimer’s research in Bristol
